What New Jersey’s drug plan do-over says about the industry

coapharm2018-05-17T13:16:26+00:00May 17, 2018|

Senate HELP Panel Explores More Clarity for 340B Drug Program

coapharm2018-05-16T13:22:05+00:00May 16, 2018|

U.S. lawmakers seek HELP for nebulous 340B Drug Discount program

coapharm2018-05-16T13:21:28+00:00May 16, 2018|

Investors, Brace Yourselves for More Drug-Price Drama

coapharm2018-05-16T13:20:49+00:00May 16, 2018|

After outcry, drugmakers decide not to triple the price of a cancer pill

coapharm2018-05-16T13:19:59+00:00May 16, 2018|

Check out how much Medicare spends on drugs

coapharm2018-05-16T13:19:12+00:00May 16, 2018|

Trump Announces Blueprint to Lower Drug Costs in US

coapharm2018-05-15T13:40:30+00:00May 15, 2018|

HHS looks to alter 340B patient definition, regulatory authority for drug pricing initiative

coapharm2018-05-15T13:39:49+00:00May 15, 2018|

Defending the ‘middlemen’ in the battle on drug prices

coapharm2018-05-15T13:38:56+00:00May 15, 2018|

The Trump Drug Pricing Plan: Short Term Reprieve, Long Term Disruption

coapharm2018-05-15T13:38:12+00:00May 15, 2018|